264 related articles for article (PubMed ID: 8869385)
21. [Neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein (MAG) antibody].
Kawagashira Y; Koike H; Sobue G
Nihon Rinsho; 2015 Sep; 73 Suppl 7():440-5. PubMed ID: 26480739
[No Abstract] [Full Text] [Related]
22. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.
Yeung KB; Thomas PK; King RH; Waddy H; Will RG; Hughes RA; Gregson NA; Leibowitz S
J Neurol; 1991 Oct; 238(7):383-91. PubMed ID: 1660064
[TBL] [Abstract][Full Text] [Related]
23. [Fatal peripheral neuropathy with predominant motor involvement associated with anti-MAG IgM monoclonal gammapathy].
Antoine JC; Steck A; Michel D
Rev Neurol (Paris); 1993; 149(8-9):496-9. PubMed ID: 7516570
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
Ponsford S; Willison H; Veitch J; Morris R; Thomas PK
Muscle Nerve; 2000 Feb; 23(2):164-74. PubMed ID: 10639606
[TBL] [Abstract][Full Text] [Related]
25. Secretions of anti-myelin-associated glycoprotein antibodies by B cells from patients with neuropathy and nonmalignant monoclonal gammopathy.
Spatz L; Latov N
Cell Immunol; 1986 Dec; 103(2):434-40. PubMed ID: 2433053
[TBL] [Abstract][Full Text] [Related]
26. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.
Galassi G; Tondelli M; Ariatti A; Benuzzi F; Nichelli P; Valzania F
Int J Neurosci; 2017 May; 127(5):439-447. PubMed ID: 27188752
[TBL] [Abstract][Full Text] [Related]
27. Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody.
Kawagashira Y; Koike H; Ohyama K; Hashimoto R; Iijima M; Adachi H; Katsuno M; Chapman M; Lunn M; Sobue G
J Neurol Sci; 2015 Jan; 348(1-2):67-73. PubMed ID: 25467141
[TBL] [Abstract][Full Text] [Related]
28. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
Ilyas AA; Quarles RH; Dalakas MC; Brady RO
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6697-700. PubMed ID: 2413445
[TBL] [Abstract][Full Text] [Related]
29. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
30. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.
Weiss MD; Dalakas MC; Lauter CJ; Willison HJ; Quarles RH
J Neuroimmunol; 1999 Mar; 95(1-2):174-84. PubMed ID: 10229128
[TBL] [Abstract][Full Text] [Related]
31. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy.
Gabriel JM; Erne B; Bernasconi L; Tosi C; Probst A; Landmann L; Steck AJ
Acta Neuropathol; 1998 May; 95(5):540-6. PubMed ID: 9600601
[TBL] [Abstract][Full Text] [Related]
32. Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component.
Baldini L; Nobile-Orazio E; Guffanti A; Barbieri S; Carpo M; Cro L; Cesana B; Damilano I; Maiolo AT
Am J Hematol; 1994 Jan; 45(1):25-31. PubMed ID: 7504399
[TBL] [Abstract][Full Text] [Related]
33. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
Tagawa Y; Yuki N; Hirata K
Muscle Nerve; 2000 Jun; 23(6):895-9. PubMed ID: 10842265
[TBL] [Abstract][Full Text] [Related]
34. [Detection of antibodies binding to myelin in 75 neuropathies associated with IgM gammopathy].
Campant RM; Caudie C; Kopp N; Lombard C; Later R
Ann Biol Clin (Paris); 1999; 57(1):69-75. PubMed ID: 9920969
[TBL] [Abstract][Full Text] [Related]
35. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide.
Eurelings M; Moons KG; Notermans NC; Sasker LD; De Jager AE; Wintzen AR; Wokke JH; Van den Berg LH
Neurology; 2001 Jan; 56(2):228-33. PubMed ID: 11160960
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
[TBL] [Abstract][Full Text] [Related]
37. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.
Vital A; Vital C; Julien J; Baquey A; Steck AJ
Acta Neuropathol; 1989; 79(2):160-7. PubMed ID: 2480693
[TBL] [Abstract][Full Text] [Related]
38. Anti-myelin-associated glycoprotein neuropathy.
Steck AJ; Stalder AK; Renaud S
Curr Opin Neurol; 2006 Oct; 19(5):458-63. PubMed ID: 16969155
[TBL] [Abstract][Full Text] [Related]
39. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S
J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732
[TBL] [Abstract][Full Text] [Related]
40. Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy.
Baron M; Lozeron P; Harel S; Bengoufa D; Vignon M; Asli B; Malphettes M; Parquet N; Brignier A; Fermand JP; Kubis N; Arnulf B
J Neurol; 2017 Jun; 264(6):1132-1135. PubMed ID: 28484839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
